Reese David M

Amgen Inc · EVP & Chief Technology Officer

Reese David M is listed in filings as EVP & Chief Technology Officer at Amgen Inc. This profile follows SEC Form 4 activity through May 11, 2026, including sale activity. Recent filings connect the profile to Amgen Inc (AMGN). The current snapshot covers public activity from Feb 21, 2025 to May 11, 2026. Reported amounts are shown as $184.1K to $6.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Amgen IncAMGN$3M8.7k sharesSellFeb 19, 2025$293.22$364.17